Publication

Revies Articles

• 「δ Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects」
  Hirayama, S.; Fujii, H.
  Curr. Top. Med. Chem. Ed. By Fujii, H., Bentham Science, 20, 31, pp.2889–2902, 2020.
• 「Exploring μ-Opioid Receptor Splice Variants as a Specific Molecular Target for New Analgesics」
  Mizoguchi, H.; Fujii, H.
  Curr. Top. Med. Chem. Ed. By Fujii, H., Bentham Science, 20, 31, pp.2866–2877, 2020.
• Dibenzofuran-4,6-bis(oxazoline) (DBFOX). A novel trans-chelating bis(oxazoline) ligand for asymmetric reactions.
  Itoh, K.;, Sibi, M. P.
  Org. Biomol. Chem., Vol.16, pp.5551-5565, 2018.
• オピオイド受容体スプライスバリアント
  藤井秀明, 平山重人
  ペインクリニック, Vol.38, pp.S196-S202, 2017.
• Essential Structure of the κ Opioid Receptor Agonist Nalfurafine for Binding to the κ Receptor.
  Nagase,H.; Fujii, H.
  Curr. Pharm. Des., Vol.20, pp.7400-7414, 2014.
• Non-peptidic δ Opioid Receptor Agonists and Antagonists (2000-2012)
  Fujii, H.; Takahashi, T.; Nagase, H.
  Exp. Opin. Ther. Patents, Vol.23, No.9, pp.1181-1208, 2013.
• Design and Synthesis of Novel Opioid Ligands and Their Pharmacologies.
  Nagase, H.; Fujii, H.
  Heterocycles, Vol.85, No.8, pp.1821-1867, 2012.
• 受容体オリゴマーの新展開 -新たな創薬標的としての可能性-
  藤井秀明, 平山重人, 長瀬　博
  化学, Vol.66, No.9, pp.70-71, 2011.
• Rational Drug Design of Selective εOpioid Receptor Agonist TAN-821 and Antagonist TAN-1014.
  Fujii, H.; Nagase, H.
  Curr. Med. Chem., 13, pp.1109-1118, 2006.